Skip to content
The Policy VaultThe Policy Vault

pyrimethamineCareFirst (Caremark)

Congenital toxoplasmosis

Initial criteria

  • The drug is being prescribed for the treatment of congenital toxoplasmosis in a pediatric patient.

Approval duration

12 months